scispace - formally typeset
M

Mary Farrington

Researcher at University of Washington

Publications -  9
Citations -  1259

Mary Farrington is an academic researcher from University of Washington. The author has contributed to research in topics: Antibody & Antigen. The author has an hindex of 6, co-authored 7 publications receiving 1231 citations.

Papers
More filters
Journal ArticleDOI

CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

TL;DR: In this paper, CD40 ligand (gp39) mRNA expression by activated lymphocytes from CVI patients as a group was significantly depressed (P < 0.0001) compared with normal controls (n = 32).
Journal ArticleDOI

Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin.

TL;DR: In this paper, B cells from all CVI patients underwent normal proliferation and synthesized normal quantities of IgE in the presence of anti-CD40 and IL-4, and four patterns of Ig isotype synthesis were observed.
Journal ArticleDOI

Regulation of Antibody Responses: The Role of Complement and Adhesion Molecules

TL;DR: Patients and guinea pigs deficient of early complement component and LAD patients responded to repeated phage immunization with depressed antibody titers, lack of or inadequate amplification, and failure to switch from IgM to IgG, suggesting a defect in generating antigen-specific memory cells.
Journal ArticleDOI

Effect of IL-2 on immunoglobulin production by anti-CD40-activated human B cells: synergistic effect with IL-10 and antagonistic effect with IL-4.

TL;DR: It is demonstrated that IL-2 plays an active role in the regulation of Ig production via CD40 by anti-CD40-activated B cells, suggesting that in a subgroup of CVI patients theIL-2 deficiency may contribute to the observed hypogammaglobulinemia.